Literature DB >> 14631458

Buspirone for anxiety and agitation in dementia.

J P Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14631458      PMCID： PMC257799     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  7 in total

Review 1.  Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.

Authors:  J E Mintzer; O Brawman-Mintzer
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

Review 2.  Buspirone: future directions.

Authors:  J T Apter; L A Allen
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

3.  Short-term buspirone treatment in disinhibition with dementia.

Authors:  J W Tiller; J A Dakis; J M Shaw
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

4.  Efficacy of buspirone in the treatment of dementia with aggression.

Authors:  J C Holzer; D R Gitelman; B H Price
Journal:  Am J Psychiatry       Date:  1995-05       Impact factor: 18.112

5.  Treatment of the agitation of late-life psychosis and Alzheimer's disease.

Authors:  C Salzman
Journal:  Eur Psychiatry       Date:  2001-01       Impact factor: 5.361

6.  Buspirone's efficacy in organic-induced aggression.

Authors:  S W Stanislav; T Fabre; M L Crismon; A Childs
Journal:  J Clin Psychopharmacol       Date:  1994-04       Impact factor: 3.153

7.  The use of buspirone in primary care.

Authors:  Hani Raoul Khouzam; Robert Emes
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2002-07       Impact factor: 1.098
  7 in total
  7 in total

1.  Treatments for Depression in Older Persons with Dementia.

Authors:  Zvi D Gellis; Kimberly P McClive-Reed; Ellen Brown
Journal:  Ann Longterm Care       Date:  2009-02-02

Review 2.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.

Authors:  Anna Borisovskaya; Marcella Pascualy; Soo Borson
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

4.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

Review 5.  Managing anxiety associated with neurodegenerative disorders.

Authors:  Brian P Gomoll; Anand Kumar
Journal:  F1000Prime Rep       Date:  2015-01-05

6.  Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder.

Authors:  Sandipan Bhattacharjee; Jeannie K Lee; Nina Vadiei; Asad E Patanwala; Daniel C Malone; Shannon M Knapp; Wei-Hsuan Lo-Ciganic; William J Burke
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-08       Impact factor: 2.570

Review 7.  Management of the behavioral and psychological symptoms of dementia.

Authors:  Elizabeth C Hersch; Sharon Falzgraf
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.